Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Monte Rosa Therapeutics, a clinical-stage biotech company specializing in molecular glue degrader medicines, announced management's participation in upcoming investor conferences, including virtual and in-person fireside chats. The company highlighted its innovative AI-driven drug discovery platform and its leading pipeline addressing autoimmune, i…